Literature DB >> 24077284

Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis.

S Cagnet1, M M Faraldo1, M Kreft2, A Sonnenberg2, K Raymond1, M A Glukhova1.   

Abstract

The constitutive activation of β-catenin signaling in the mammary basal epithelial cell layer in transgenic K5ΔNβcat mice leads to basal-type tumor development. Integrins of the β1 family and integrin-mediated signaling events have an important role in breast tumor growth and progression. We show here that the deletion of α3β1 integrin, a major laminin receptor, from the basal layer of the mammary epithelium of K5ΔNβcat mice completely prevented the tumorigenesis induced by β-catenin signaling. Moreover, the depletion of α3β1 integrin from a spontaneously transformed mouse mammary basal epithelial cell line (MEC) prevented the cells from forming colonies in soft agar and greatly reduced tumor development in orthotopic grafts. Inhibition of the integrin signaling intermediates Rac1 or PAK1 (P21-activated Kinase 1) in MEC affected tumor cell growth in soft agar, whereas the expression of activated forms of these effectors in α3-depleted cells rescued the capacity of these cells to grow in non-adherent conditions. Similarly, the tumorigenic potential of α3-depleted cells was restored by the expression of activated PAK1, as assessed by orthotopic transplantation assay. In three-dimensional Matrigel culture, MEC survival and proliferation were affected by the depletion of α3β1 integrin, which also significantly decreased the activation of focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK) and c-Jun NH2-terminal kinase (JNK). Our data suggest that the activation of signaling cascades downstream from α3β1 and involving the Rac1/PAK1 pathway, MAPK and JNK, promotes prosurvival and proproliferative signals required for the malignant growth of basal mammary epithelial cells, providing further insight into the molecular mechanisms underlying breast cancer initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24077284     DOI: 10.1038/onc.2013.391

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.

Authors:  Bernardo Nuche-Berenguer; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2015-05-12

2.  A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for N-glycan sialylation in cancer cells.

Authors:  Tomoya Isaji; Sanghun Im; Akihiko Kameyama; Yuqin Wang; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

Review 3.  Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance.

Authors:  Laetitia Seguin; Jay S Desgrosellier; Sara M Weis; David A Cheresh
Journal:  Trends Cell Biol       Date:  2015-01-05       Impact factor: 20.808

4.  Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells.

Authors:  Sita Subbaram; Scott P Lyons; Kimberly B Svenson; Sean L Hammond; Lorena G McCabe; Sridar V Chittur; C Michael DiPersio
Journal:  J Cell Sci       Date:  2014-01-16       Impact factor: 5.285

5.  α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway.

Authors:  Afshin Varzavand; Will Hacker; Deqin Ma; Katherine Gibson-Corley; Maria Hawayek; Omar J Tayh; James A Brown; Michael D Henry; Christopher S Stipp
Journal:  Cancer Res       Date:  2016-09-28       Impact factor: 12.701

Review 6.  β1 and β4 integrins: from breast development to clinical practice.

Authors:  Paola Nisticò; Francesca Di Modugno; Sheila Spada; Mina J Bissell
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

7.  Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors.

Authors:  Wenwu Xiao; Tianhong Li; Fernanda C Bononi; Diana Lac; Ivy A Kekessie; Yanlei Liu; Eduardo Sanchez; Anisha Mazloom; Ai-Hong Ma; Jia Lin; Jimmy Tran; Kevin Yang; Kit S Lam; Ruiwu Liu
Journal:  EJNMMI Res       Date:  2016-02-27       Impact factor: 3.138

8.  β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation.

Authors:  Aejaz Sayeed; Huimin Lu; Qin Liu; David Deming; Alexander Duffy; Peter McCue; Adam P Dicker; Roger J Davis; Dmitry Gabrilovich; Ulrich Rodeck; Dario C Altieri; Lucia R Languino
Journal:  Oncotarget       Date:  2016-08-16

9.  Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Naoko Kikkawa; Takayuki Arai; Atsushi Okato; Akira Kurozumi; Mayuko Kato; Koji Katada; Yoshitaka Okamoto; Naohiko Seki
Journal:  Cancer Sci       Date:  2017-07-04       Impact factor: 6.716

Review 10.  Every step of the way: integrins in cancer progression and metastasis.

Authors:  Hellyeh Hamidi; Johanna Ivaska
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.